Article info

PDF

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

Authors

  1. Correspondence to Dr Murray B Urowitz; m.urowitz{at}utoronto.ca
View Full Text

Citation

Urowitz MB, Isenberg DA, Wallace DJ
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study

Publication history

  • Received May 20, 2015
  • Revision received July 6, 2015
  • Accepted July 10, 2015
  • First published August 11, 2015.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.